Overview
Perioral myoclonia with absences (POMA) is a rare form of idiopathic generalized epilepsy characterized by absence seizures accompanied by rhythmic myoclonic jerks of the muscles around the mouth (perioral region), including the lips, chin, and jaw. This condition was first described by Panayiotopoulos in 1994 and is sometimes referred to as Panayiotopoulos-type perioral myoclonia with absences. The hallmark feature is brief episodes of impaired consciousness (absence seizures) during which involuntary, rhythmic twitching movements of the perioral muscles occur. These myoclonic jerks are typically subtle and may be accompanied by mild tonic contraction of the jaw muscles. The electroencephalogram (EEG) during seizures shows generalized 3 Hz spike-and-wave or polyspike-and-wave discharges. The condition primarily affects the central nervous system. POMA typically begins in childhood or adolescence, though onset can extend into adulthood. The absence seizures may be frequent and can be provoked by hyperventilation. Some patients may also experience generalized tonic-clonic seizures. The condition tends to be resistant to treatment compared to other forms of absence epilepsy, and seizures often persist into adulthood. Standard antiepileptic medications used for generalized epilepsies, such as valproate, ethosuximide, and lamotrigine, are the mainstays of treatment, though complete seizure control may be difficult to achieve. There is ongoing debate regarding whether POMA represents a distinct epilepsy syndrome or a variant of other idiopathic generalized epilepsies. A family history of epilepsy is common, suggesting a genetic predisposition, though the precise genetic basis has not been fully elucidated.
Also known as:
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Childhood to adulthood
Can begin any time from childhood through adulthood
FDA & Trial Timeline
1 eventMarmara University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Perioral myoclonia with absences.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Perioral myoclonia with absences at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Perioral myoclonia with absences.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
5 resourcesVALPROIC ACID
AbbVie
Epilepsy
Carbamazepine, Carbamazepin
Novartis
Epilepsy
Valtoco
Neurelis
Epilepsy
Nayzilam
UCB
Generalized Epilepsy
Carbamazepine
Novartis
Epilepsy
Travel Grants
No travel grants are currently matched to Perioral myoclonia with absences.
Community
No community posts yet. Be the first to share your experience with Perioral myoclonia with absences.
Start the conversation →Latest news about Perioral myoclonia with absences
Disease timeline:
New recruiting trial: Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke
A new clinical trial is recruiting patients for Perioral myoclonia with absences
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Perioral myoclonia with absences
What is Perioral myoclonia with absences?
Perioral myoclonia with absences (POMA) is a rare form of idiopathic generalized epilepsy characterized by absence seizures accompanied by rhythmic myoclonic jerks of the muscles around the mouth (perioral region), including the lips, chin, and jaw. This condition was first described by Panayiotopoulos in 1994 and is sometimes referred to as Panayiotopoulos-type perioral myoclonia with absences. The hallmark feature is brief episodes of impaired consciousness (absence seizures) during which involuntary, rhythmic twitching movements of the perioral muscles occur. These myoclonic jerks are typic
How is Perioral myoclonia with absences inherited?
Perioral myoclonia with absences follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Perioral myoclonia with absences typically begin?
Typical onset of Perioral myoclonia with absences is childhood to adulthood. Age of onset can vary across affected individuals.
What treatment and support options exist for Perioral myoclonia with absences?
5 patient support programs are currently tracked on UniteRare for Perioral myoclonia with absences. See the treatments and support programs sections for copay assistance, eligibility, and contact details.